Your browser is no longer supported. Please, upgrade your browser.
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E26.07 EPS (ttm)6.65 Insider Own0.10% Shs Outstand2.63B Perf Week0.69%
Market Cap456.47B Forward P/E16.59 EPS next Y10.45 Insider Trans0.00% Shs Float2.63B Perf Month3.21%
Income17.77B PEG3.41 EPS next Q2.36 Inst Own69.10% Short Float0.60% Perf Quarter3.76%
Sales89.19B P/S5.12 EPS this Y-4.20% Inst Trans0.05% Short Ratio2.42 Perf Half Y8.01%
Book/sh25.02 P/B6.93 EPS next Y8.06% ROA8.70% Target Price187.39 Perf Year17.76%
Cash/sh9.35 P/C18.54 EPS next 5Y7.65% ROE22.90% 52W Range133.65 - 174.50 Perf YTD10.15%
Dividend4.24 P/FCF47.02 EPS past 5Y-0.30% ROI14.60% 52W High-0.65% Beta0.71
Dividend %2.45% Quick Ratio1.00 Sales past 5Y3.30% Gross Margin67.10% 52W Low29.71% ATR1.89
Employees134500 Current Ratio1.30 Sales Q/Q7.90% Oper. Margin18.50% RSI (14)64.77 Volatility0.97% 1.13%
OptionableYes Debt/Eq0.51 EPS Q/Q12.70% Profit Margin16.50% Rel Volume0.73 Prev Close174.39
ShortableYes LT Debt/Eq0.46 EarningsJul 21 BMO Payout71.20% Avg Volume6.51M Price173.36
Recom1.90 SMA201.73% SMA503.43% SMA2008.27% Volume4,771,450 Change-0.59%
May-28-21Resumed Morgan Stanley Overweight $187
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Aug-04-21 05:16PM  
03:07PM  
02:43PM  
02:12PM  
12:58PM  
11:04AM  
10:39AM  
10:32AM  
09:23AM  
Aug-03-21 05:38PM  
03:28PM  
02:25PM  
07:22AM  
Aug-02-21 06:18PM  
05:21PM  
04:29PM  
01:55PM  
01:05PM  
12:02PM  
10:41AM  
10:09AM  
07:47AM  
04:46AM  
Aug-01-21 09:34AM  
08:00AM  
06:28AM  
06:15AM  
Jul-31-21 06:05AM  
Jul-30-21 02:17PM  
01:58PM  
01:56PM  
01:34PM  
12:58PM  
12:31PM  
11:13AM  
09:54AM  
08:00AM  
06:15AM  
05:02AM  
Jul-29-21 06:30PM  
02:06PM  
12:49PM  
11:14AM  
11:01AM  
10:16AM  
07:32AM  
06:32AM  
06:09AM  
06:00AM  
12:25AM  
Jul-28-21 11:24PM  
09:35PM  
07:00PM  
05:28PM  
05:05PM  
03:45PM  
02:02PM  
01:51PM  
01:47PM  
12:55PM  
11:59AM  
11:45AM  
07:14AM  
02:05AM  
Jul-27-21 10:27PM  
05:37PM  
03:24PM  
02:12PM  
12:31PM  
11:14AM  
05:55AM  
Jul-26-21 03:59PM  
02:50PM  
02:05PM  
04:14AM  
03:17AM  
Jul-25-21 06:31PM  
06:15AM  
Jul-24-21 06:00AM  
Jul-23-21 04:01PM  
03:41PM  
02:29PM  
01:53PM  
12:55PM  
11:43AM  
11:00AM  
08:01AM  
06:12AM  
06:00AM  
Jul-22-21 04:25PM  
03:04PM  
02:36PM  
11:30AM  
10:28AM  
10:16AM  
10:05AM  
09:26AM  
09:15AM  
09:00AM  
08:00AM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM